Landos Biopharma
Why Robinhood?
You can watch LABP and buy or sell other stocks, ETFs, and their options commission-free!About LABP
Landos Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of novel, oral, once-daily therapeutics for patients with certain immunology diseases. It offers NX-13, a novel, oral, gut-restricted compound for the treatment of inflammatory bowel disease, which targets the NLRX1 pathway.
LABP Key Statistics
Stock Snapshot
The current Landos Biopharma(LABP) stock price is $3.39, with a market capitalization of 71.47M. The stock trades at a price-to-earnings (P/E) ratio of -5.74.
On 2026-05-21, Landos Biopharma(LABP) stock opened at —, reached a high of —, and a low of —.
The Landos Biopharma(LABP)'s current trading volume is 0.
In the last year, Landos Biopharma(LABP) shares hit a 52-week high of $22.94 and a 52-week low of $21.90.
In the last year, Landos Biopharma(LABP) shares hit a 52-week high of $22.94 and a 52-week low of $21.90.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.